<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xml:lang="en" lang="en">
<head>
<meta charset="utf-8"/>
<title>Foundations of Inorganic Chemistry</title>
<link rel="stylesheet" href="../styles/stylesheet.css" type="text/css"/>
</head>
<body>
<div>
<a id="page_ii" class="page">Page ii, Foundations of Inorganic Chemistry</a>
<table class="width100a">
<tr>
<td style="vertical-align:top;" class="borderbw25"><p class="fmhead1">Foundations of Inorganic Chemistry</p></td>
</tr>
<tr>
<td style="vertical-align:top;"><p class="fmauthor">Mark J. Winter</p></td>
</tr>
<tr>
<td style="vertical-align:top;"><p class="fmauthor1">Department of Chemistry, University of Sheffield</p></td>
</tr>
<tr>
<td style="vertical-align:top;"><p class="fmauthor">John E. Andrew</p></td>
</tr>
<tr>
<td style="vertical-align:top;"><p class="fmauthor1">(retired) Head of Chemistry, Hall Cross Comprehensive School, Doncaster</p></td></tr>
</table>
<p class="fmpub"><img src="../images/pub-1.jpg" alt="images"/></p>
<p class="fmindent">AstraZeneca is one of the world&#x2019;s leading pharmaceutical companies with a strong research base. Its skill and innovative ideas in organic chemistry and bioscience create products designed to fight disease in seven key therapeutic areas: cancer, cardiovascular, central nervous system, gastrointestinal, infection, pain control, and respiratory.</p>
<p class="fmnoindent">AstraZeneca was formed through the merger of Astra AB of Sweden and Zeneca Group PLC of the UK. The company is headquartered in the UK with over 50,000 employees worldwide. R&amp;D centres of excellence are in Sweden, the UK, and USA with R&amp;D headquarters in S&#xF6;dert&#xE4;lje, Sweden.</p>
<p class="fmnoindent">AstraZeneca is committed to the support of education in chemistry and chemical engineering.</p>
<p class="fmpub"><img src="../images/pub.jpg" alt="images"/></p>
</div>
</body>
</html>